Cosmos Health Inc. (COSM) income statement
COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30113% above fair value
$2.95+0.10 (+3.51%)
Close on Nov 18, 2026Market cap $296.87MP/E –Yield –
Cosmos Health Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 10.3%
- Operating margin
- -24.9%
- Net margin
- -33.1%
- Return on equity, FY2025
- -89.1%
Financial strength
- Current ratio
- 1.05
- Debt to equity
- 0.06
- Debt to assets
- 1.9%
- Cash to current liabilities
- 5.2%
Valuation
- P/E ratio
- –
- Price to sales
- 4.03
- Price to book
- 14.36
- Dividend yield
- –
See a number that looks wrong?